Effects of Single-Nucleotide Polymorphisms of FMO3 and FMO6 Genes on Pharmacokinetic Characteristics of Sulindac Sulfide in Premature Labor
Authors:
- 1 January 2014
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 42 (1) , 40-43
Abstract
This study aimed to investigate the effects of polymorphisms of the flavin-containing mono-oxygenase 3 (FMO3) and flavin-containing mono-oxygenase 6 (FMO6) genes on the pharmacokinetics of sulindac sulfide, the active metabolite of sulindac, in patients with preterm labor. Ten single-nucleotide polymorphisms (SNPs) were genotyped, and plasma sulindac sulfide concentrations were measured at 0, 1.5, 4, and 10 hours after drug administration. The area under the curve from time 0 to the last sampling time point (AUClast) for sulindac sulfide was obtained. The AUClast of sulindac sulfide was significantly higher in patients with variant-type homozygotes of FMO3 (rs909530) than those with ancestral alleles or heterozygotes. FMO3 (rs2266780) was in complete linkage disequilibrium with FMO6 (rs7885012), and there was marginal significance between the genotypes (P = 0.049). From multiple linear regression models, FMO3 (rs909530) was found to have significant influence on the AUClast of sulindac sulfide after adjusting for gestational age, weight, and all studied SNPs. The predictive contribution of rs909530 to the variability of sulindac sulfide AUClast was 27.0%. In conclusion, the results of this study could help clinicians predict the efficacies and side effects of sulindac in the development of individualized treatment of patients with preterm labor.Keywords
This publication has 24 references indexed in Scilit:
- Pharmacogenomics Variation in Drug Metabolizing Enzymes and Transporters in Relation to Docetaxel Toxicity in Lebanese Breast Cancer Patients: Paving the Way for OMICs in Low and Middle Income CountriesOMICS: A Journal of Integrative Biology, 2013
- Genetic Polymorphisms of Flavin Monooxygenase 3 in Sulindac-Induced Regression of Colorectal Adenomas in Familial Adenomatous PolyposisCancer Epidemiology, Biomarkers & Prevention, 2005
- Genetic Polymorphisms of Human Flavin Monooxygenase 3 in Sulindac-Mediated Primary Chemoprevention of Familial Adenomatous PolyposisClinical Cancer Research, 2004
- Organization and evolution of the flavin-containing monooxygenase genes of human and mousePharmacogenetics, 2004
- Trimethylaminuria and a humanFMO3 mutation databaseHuman Mutation, 2003
- Interindividual Differences of Human Flavin-Containing Monooxygenase 3: Genetic Polymorphisms and Functional VariationDrug Metabolism and Disposition, 2002
- Alternative Processing of the Human FMO6 Gene Renders Transcripts Incapable of Encoding a Functional Flavin-Containing MonooxygenaseMolecular Pharmacology, 2002
- Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FMO3) gene in patients with fish-odour syndromePharmacogenetics, 2000
- Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenasesBiochemical Pharmacology, 2000
- The Mammalian Flavin-Containing Monooxygenases: Molecular Characterization and Regulation of ExpressionToxicology and Applied Pharmacology, 1994